MEMORANDUM - WHO

MEMORANDUM November 30, 2012 TO: world health organization Expert Committee on the selection and Use of Essential Medicines FROM: PATH, on behalf of the Chlorhexidine Working Group RE: Change requested in the next world health organization Model List of Essential Medicines for Children from the current listing of Chlorhexidine Solution: 5% (digluconate); 20% (digluconate) (needs to be diluted prior to use for cord care) to: chlorhexidine digluconate solution or gel, delivering 4% chlorhexidine for umbilical cord care Background The 2011 world health organization (WHO) Model List of Essential Medicines for Children (EMLc)1includes chlorhexidine for umbilical cord care under section 15. DISINFECTANTS AND ANTISEPTICS, subsection Antiseptics. The listing is as follows: Chlorhexidine Solution: 5% (digluconate); 20% (digluconate) (needs to be diluted prior to use for cord care) The 17th Expert Committee on the selection and Use of Essential Medicines convened by WHO in 2009 concluded that data from a community based, cluster randomized controlled trial (RCT) in Nepal showed a significant reduction in neonatal mortality after use of a 4% chlorhexidine solution ( chlorhexidine digluconate) for umbilical cord This was sufficient to include such a product and indication for use in the WHO EMLc.

MEMORANDUM November 30, 2012 TO: World Health Organization Expert Committee on the Selection and Use of Essential Medicines FROM: PATH, on behalf of the Chlorhexidine Working Group RE: Change requested in the next World Health Organization Model List of Essential Medicines for Children from the current listing of Chlorhexidine Solution: 5%

Loading..

Tags:

  Health, World health organization, World, Organization, Selection, Memorandum, Selection and use

Information

Related search queries